3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Hodgkin Disease
6
Lymphoma, Large B-Cell, Diffuse
5
Triple Negative Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma
4
Rhabdomyosarcoma
3
Lymphoma, Non-Hodgkin
3
Leukemia
3
Burkitt Lymphoma
3
Sarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Neuroblastoma
2
Multiple Myeloma
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Teratoma
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Sarcoma, Ewing
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Pancreatic Neoplasms
1
Pain
1
Interventions
Vincristine
5
Etoposide
5
Carboplatin
5
Melphalan
3
Topotecan
2
Platinum Compounds
2
Drug Therapy
2
Cyclophosphamide
2
Cryotherapy
2
pembrolizumab
1
omburtamab I-131
1
abemaciclib
1
Wechsler Scales
1
Watchful Waiting
1
Thiotepa
1
Surveys and Questionnaires
1
Specimen Handling
1
Observation
1
Microscopy, Acoustic
1
Memory and Learning Tests
1
Magnetic Resonance Spectroscopy
1
Lasers, Semiconductor
1
Lasers
1
LY2940680
1
Hyperthermia, Induced
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eye Enucleation
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Retinoblastoma
×
pegfilgrastim
×
1 year
×
Clear all
No trials found.